Send Inquiry

Request To Call Back

Metoprolol Succinate

Name: Metoprolol Succinate
Brand: AXIS PHARMA CHEM
Price: 1650.0 INR
Availability: InStock

Price 1650.0 INR/ Kilograms

Get a Price/Quote

MOQ : 25 Kilograms

Metoprolol Succinate Specification

HS Code
29420090

Molecular Formula
C34H56N2O10

Solubility
Freely soluble in water and methanol, sparingly soluble in ethanol

Pacakaging (Quantity Per Box)
100 gm

Assay
Between 98.0% to 102.0%

Suitable For
Adults

Dosage Guidelines
As per physicians direction

Appearance
White to off-white powder

Purity
99%

Melting Point
120-124°C

CAS No
98418-47-4

Physical Form
Powder

Type
Other

Ingredients
Other

Feature
Accurate composition, Long shelf life

Storage Instructions
Other

Stability
Stable under recommended storage conditions

Category
Pharmaceutical Intermediate

Molecular Weight
652.82 g/mol

Standard
USP/EP

Impurity Profile
Within specified limits

Therapeutic Class
Beta-blocker

Metoprolol Succinate Trade Information

Minimum Order Quantity
25 Kilograms

FOB Port
BHAVNAGAR,MUNDRA,NHAVA

Payment Terms
Cash Against Delivery (CAD), Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Cash Advance (CA), Cash in Advance (CID), Western Union, Cheque, Days after Acceptance (DA)

Supply Ability
100 Kilograms Per Day

Delivery Time
7 Days

Packaging Details
25KG

Main Domestic Market
All India

Certifications
CETIFIED WITH GPCB

About Metoprolol Succinate

Metoprolol Succinate USP is the United States Pharmacopeia USPgrade version of Metoprolol Succinate a beta1 selective adrenergic receptor blocker betablocker It is commonly prescribed to manage several cardiovascular conditions

Key Details

Generic Name Metoprolol Succinate
Brand Names ToprolXL others
USP Indicates it meets the quality purity strength and consistency standards set by the United States Pharmacopeia

Indications

Metoprolol Succinate is used to treat
Hypertension high blood pressure
Angina pectoris chest pain
Heart failure particularly NYHA Class II or III
Postmyocardial infarction heart attack management to reduce risk of death

Pharmacology

Class Beta1 selective betablocker
Mechanism Reduces heart rate cardiac output and blood pressure by blocking beta1 adrenergic receptors in the heart
Formulation Extendedrelease ER tablets for oncedaily dosing

Common Dosages

HypertensionAngina Typically 25100 mg once daily
Heart Failure Starting at 12525 mg once daily titrated up as tolerated to a target dose eg 200 mgday

Important Notes

Should not be abruptly discontinued as it can cause rebound hypertension or exacerbate angina
Adjust dose with caution in patients with bradycardia hypotension or renalhepatic impairment
May cause side effects like fatigue dizziness bradycardia depression or cold extremities
Would you like detailed pharmacokinetics brand comparisons or patient counseling information

High-Quality Beta-Blocker Intermediate

Metoprolol Succinate is rigorously manufactured to meet USP/EP standards, ensuring reliability for pharmaceutical formulations. With its precise assay and impurity profile within limits, it is suitable for adult therapy applications under professional guidance.

Optimized Stability and Purity

This product guarantees a long shelf life of five years when stored as directed. Its stable physical form ensures consistent performance, while the high purity (99%) and accurate composition make it ideal for pharmaceutical development and bulk supply.

FAQs of Metoprolol Succinate:

Q: How should Metoprolol Succinate be stored to ensure its stability?

A: Metoprolol Succinate should be stored in a cool, dry place under recommended storage conditions as indicated, ensuring the container is tightly closed to maintain its stability and extended shelf life.

Q: What are the main benefits of using Metoprolol Succinate as a pharmaceutical intermediate?

A: The main advantages include its precise composition, high level of purity (99%), compliance with USP/EP standards, and a robust stability profile, making it highly reliable for pharmaceutical manufacturing and formulation.

Q: When is Metoprolol Succinate typically administered?

A: Usage and dosage guidelines are determined by a physician, with Metoprolol Succinate generally indicated for adults as part of therapeutic regimes requiring a beta-blocker.

Q: Where is Metoprolol Succinate commonly supplied or used?

A: As an intermediate, it is distributed, imported, manufactured, and supplied primarily within the pharmaceutical sector, especially across India for research, formulation, or large-scale production.

Q: What is the process for obtaining and using Metoprolol Succinate?

A: You can acquire Metoprolol Succinate from licensed distributors, manufacturers, or suppliers. Its use in formulations should always follow regulatory standards and professional medical direction.

Q: How does the impurity profile and assay of Metoprolol Succinate ensure quality?

A: Metoprolol Succinate is analyzed to confirm its impurity content is within specified limits and that its assay falls within 98.0% to 102.0%, ensuring consistency and safety in pharmaceutical applications.

Tell us about your requirement